Cargando…

Prolonged cross-bridge binding triggers muscle dysfunction in a Drosophila model of myosin-based hypertrophic cardiomyopathy

K146N is a dominant mutation in human β-cardiac myosin heavy chain, which causes hypertrophic cardiomyopathy. We examined how Drosophila muscle responds to this mutation and integratively analyzed the biochemical, physiological and mechanical foundations of the disease. ATPase assays, actin motility...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kronert, William A, Bell, Kaylyn M, Viswanathan, Meera C, Melkani, Girish C, Trujillo, Adriana S, Huang, Alice, Melkani, Anju, Cammarato, Anthony, Swank, Douglas M, Bernstein, Sanford I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2018
Materias:	Cell Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141233/ https://www.ncbi.nlm.nih.gov/pubmed/30102150 http://dx.doi.org/10.7554/eLife.38064

Ejemplares similares

Expression of the inclusion body myopathy 3 mutation in Drosophila depresses myosin function and stability and recapitulates muscle inclusions and weakness
por: Wang, Yang, et al.
Publicado: (2012)

A Drosophila model of dominant inclusion body myopathy type 3 shows diminished myosin kinetics that reduce muscle power and yield myofibrillar defects
por: Suggs, Jennifer A., et al.
Publicado: (2017)

Two Drosophila Myosin Transducer Mutants with Distinct Cardiomyopathies Have Divergent ADP and Actin Affinities
por: Bloemink, Marieke J., et al.
Publicado: (2011)

The UNC-45 Chaperone Is Critical for Establishing Myosin-Based Myofibrillar Organization and Cardiac Contractility in the Drosophila Heart Model
por: Melkani, Girish C., et al.
Publicado: (2011)

Myosin dilated cardiomyopathy mutation S532P disrupts actomyosin interactions, leading to altered muscle kinetics, reduced locomotion, and cardiac dilation in Drosophila
por: Trujillo, Adriana S., et al.
Publicado: (2021)

The Relay/Converter Interface Influences Hydrolysis of ATP by Skeletal Muscle Myosin II
por: Bloemink, Marieke J., et al.
Publicado: (2016)

The R369 Myosin Residue within Loop 4 Is Critical for Actin Binding and Muscle Function in Drosophila
por: Trujillo, Adriana S., et al.
Publicado: (2022)

Drosophila as a potential model to ameliorate mutant Huntington-mediated cardiac amyloidosis
por: Trujillo, Adriana S, et al.
Publicado: (2014)

Huntington's Disease Induced Cardiac Amyloidosis Is Reversed by Modulating Protein Folding and Oxidative Stress Pathways in the Drosophila Heart
por: Melkani, Girish C., et al.
Publicado: (2013)

Automated evaluation of cardiac contractile dynamics and aging prediction using machine learning in a Drosophila model
por: Pant, Aniket, et al.
Publicado: (2023)

Drosophila myosin mutants model the disparate severity of type 1 and type 2B distal arthrogryposis and indicate an enhanced actin affinity mechanism
por: Guo, Yiming, et al.
Publicado: (2020)

Myosin Transducer Inter-Strand Communication Is Critical for Normal ATPase Activity and Myofibril Structure
por: Kronert, William A., et al.
Publicado: (2022)

Specific Myosin Heavy Chain Mutations Suppress Troponin I Defects in Drosophila Muscles
por: Kronert, William A., et al.
Publicado: (1999)

A Skeletal Muscle-Centric View on Time-Restricted Feeding and Obesity under Various Metabolic Challenges in Humans and Animals
por: Livelo, Christopher, et al.
Publicado: (2022)

Moderating the Myosin Motor to Treat Hypertrophic Cardiomyopathy
por: Papp, Zoltán
Publicado: (2022)

Reductions in ATPase activity, actin sliding velocity, and myofibril stability yield muscle dysfunction in Drosophila models of myosin-based Freeman–Sheldon syndrome
por: Rao, Deepti S., et al.
Publicado: (2019)

Time-restricted feeding restores muscle function in Drosophila models of obesity and circadian-rhythm disruption
por: Villanueva, Jesús E., et al.
Publicado: (2019)

Author Correction: Time-restricted feeding restores muscle function in Drosophila models of obesity and circadian-rhythm disruption
por: Villanueva, Jesús E., et al.
Publicado: (2020)

Myosins and MyomiR Network in Patients with Obstructive Hypertrophic Cardiomyopathy
por: Foglieni, Chiara, et al.
Publicado: (2022)

Stress cardiomyopathy in a patient with hypertrophic cardiomyopathy and myocardial bridging
por: Benavides, Miguel, et al.
Publicado: (2017)

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity
por: Adhikari, Arjun S., et al.
Publicado: (2019)

Profilin modulates sarcomeric organization and mediates cardiomyocyte hypertrophy
por: Kooij, Viola, et al.
Publicado: (2016)

The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy
por: Jacques, Adam M., et al.
Publicado: (2008)

Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy
por: Braunwald, Eugene, et al.
Publicado: (2023)

Rapamycin reduces neuronal mutant huntingtin aggregation and ameliorates locomotor performance in Drosophila
por: Roth, Jonathan R., et al.
Publicado: (2023)

Distortion of the Actin A-Triad Results in Contractile Disinhibition and Cardiomyopathy
por: Viswanathan, Meera C., et al.
Publicado: (2017)

Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light
por: Trivedi, Darshan V., et al.
Publicado: (2017)

Getting inside the engine - myosin modulation in hypertrophic cardiomyopathy and systolic heart failure
por: Daniels, Matthew J, et al.
Publicado: (2021)

Time-restricted feeding promotes muscle function through purine cycle and AMPK signaling in Drosophila obesity models
por: Livelo, Christopher, et al.
Publicado: (2023)

Multivessel myocardial bridging in a patient with spiral hypertrophic cardiomyopathy
por: Fritz, Timothy, et al.
Publicado: (2016)

The Hypertrophic Cardiomyopathy Myosin Mutation R453C Alters ATP Binding and Hydrolysis of Human Cardiac β-Myosin
por: Bloemink, Marieke, et al.
Publicado: (2014)

Increasing autophagy and blocking Nrf2 suppress laminopathy‐induced age‐dependent cardiac dysfunction and shortened lifespan
por: Bhide, Shruti, et al.
Publicado: (2018)

Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy
por: Toepfer, Christopher N., et al.
Publicado: (2020)

Cardiac-Restricted Expression of VCP/TER94 RNAi or Disease Alleles Perturbs Drosophila Heart Structure and Impairs Function
por: Viswanathan, Meera C., et al.
Publicado: (2016)

Unequal allelic expression of wild-type and mutated β-myosin in familial hypertrophic cardiomyopathy
por: Tripathi, Snigdha, et al.
Publicado: (2011)

Biophysical properties of human β-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy
por: Kawana, Masataka, et al.
Publicado: (2017)

Myosin Modulators: The New Era of Medical Therapy for Systolic Heart Failure and Hypertrophic Cardiomyopathy
por: Lekaditi, Dimitra, et al.
Publicado: (2021)

The NADPH Metabolic Network Regulates Human αB-crystallin Cardiomyopathy and Reductive Stress in Drosophila melanogaster
por: Xie, Heng B., et al.
Publicado: (2013)

Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner
por: Singh, Rohit R., et al.
Publicado: (2021)

Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state
por: Vander Roest, Alison Schroer, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_htnpdv8ajob1tmu2kf40amvcc4